QGEN - QIAGEN N.V.


46.88
-0.770   -1.642%

Share volume: 1,975,041
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%

$47.65
-0.77
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024
Fiscal Quarter Q1 2024 Q2 2024
Report Date 05-01-2024 08-02-2024
Total revenue 458.796 M 496.347 M
Cost of revenue 151.734 M 446.371 M
Gross profit 307.062 M 49.976 M
    -83.72%  
Operating expenses 190.022 M 192.407 M
Selling general and admin 138.689 M 143.304 M
Research and development 51.333 M 49.103 M
Total expenses 360.551 M 656.704 M
    82.14%  
Operating income 98.245 M -160.357 M
Ebit 98.245 M -160.357 M
Pretax income 102.290 M -223.451 M
    -318.45%  
Income tax 21.617 M -39.991 M
Net income basic 80.673 M -183.460 M
    -327.41%  
Net income 80.673 M -183.460 M
    -327.41%